Paul Grayson
Direttore/Membro del Consiglio presso SKYE BIOSCIENCE, INC.
Patrimonio netto: 4 M $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| J. Wolchko | M | 53 | 17 anni | |
| Punit Dhillon | M | 44 | 6 anni | |
| Kent Snyder | M | 70 | 21 anni | |
| John Mendlein | M | 64 | 17 anni | |
| Margaret Dalesandro | M | 77 | 4 anni | |
| Alicia Levey | M | - |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 10 anni |
| Mehmet Badur | M | - |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 2 anni |
| Cindy Tahl | F | 51 | 15 anni | |
| Praveen Tyle | M | 64 | 3 anni | |
| Keith Ward | M | 54 | 3 anni | |
| Deborah Charych | M | - | 1 anni | |
| Rachel F. Lane | M | - |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 4 anni |
| Christopher G. Twitty | M | 52 | 2 anni | |
| Elizabeth Alcamo | F | - |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 4 anni |
| Kaitlyn Arsenault | F | - | 3 anni | |
| Rhea Williams | F | - | 3 anni | |
| Brian Busser | M | - |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 3 anni |
| Katharina Kreymborg | M | - |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 2 anni |
| Karam Takhar | M | - | - | |
| Scott Struthers | M | 62 |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | 3 anni |
| Markus Enzelberger | M | 55 |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 4 anni |
| Stephan Kontos | M | - |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 2 anni |
| Max Eisenberg | M | - |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 5 anni |
| Thomas S. Kim | M | - | - | |
| Fan Cheong Chan | M | 72 |
University of California, Los Angeles
| 38 anni |
| Markus Warmuth | M | 53 |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 4 anni |
| Nigel Sheail | M | 59 |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 1 anni |
| Tu Diep | M | 43 | - | |
| Daniel J. Estes | M | 43 |
Radionetics Oncology, Inc.
Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | - |
| James S. Economou | M | - |
University of California, Los Angeles
| 38 anni |
| Richard D. van Doren | M | 47 |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 2 anni |
| Peter Emtage | M | - |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 3 anni |
| Andrew Schwab | M | 53 | 1 anni | |
| Robert G. Koblin | M | 92 |
University of California, Los Angeles
| 42 anni |
| Rami Hannoush | M | - |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Antony E. Rogers | M | 57 | 16 anni | |
| Kenneth T. Shimizu | M | - |
University of California, Los Angeles
| 10 anni |
| Amir Nashat | M | 51 | 13 anni | |
| Katherine Bowdish | M | 67 |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | - |
| Nishan de Silva | M | 51 |
Radionetics Oncology, Inc.
Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | 2 anni |
| Patrick W. Dennis | M | - |
University of California, Los Angeles
| 3 anni |
| Stephen D. Cooke | M | - |
University of California, Los Angeles
| 3 anni |
| Pam K. Hagenah | F | - |
University of California, Los Angeles
| 7 anni |
| Tom Muscarella | M | - |
Sanderling Management CO LLC
 Sanderling Management CO LLC Investment ManagersFinance Sanderling Management CO LLC (Sanderling Ventures) is a venture capital firm founded in 1979 by Robert G. McNeil. The firm is headquartered in San Mateo, California. | - |
| Robert Fitzgerald | M | 60 |
University of California, Los Angeles
| 7 anni |
| Kevin Andrew Frankel | M | - |
University of California, Los Angeles
| 7 anni |
| Thirumalai M. Ravi | M | - |
University of California, Los Angeles
| 7 anni |
| Ronald Dean Ormand | M | 65 |
University of California, Los Angeles
| 6 anni |
| Alex Rives | M | - | - | |
| Iain Lo | M | 62 |
University of California, Los Angeles
| 5 anni |
| Xingping Charles Yang | M | 62 |
University of California, Los Angeles
| 3 anni |
| Seth Michelson | M | - |
University of California, Los Angeles
| 4 anni |
| Ernesto Cervera | M | 66 |
University of California, Los Angeles
| 2 anni |
| Hiep Nguyen | M | - |
University of California, Los Angeles
| 5 anni |
| Montague Yort | M | 60 |
University of California, Los Angeles
| 10 anni |
| Rodrigo A. Guerra | M | 68 |
University of California, Los Angeles
| 5 anni |
| Mark L. Levin | M | - |
University of California, Los Angeles
| 7 anni |
| Stephanie Bontemps | F | - |
University of California, Los Angeles
| 7 anni |
| Andrew Evan Shapiro | M | 63 |
University of California, Los Angeles
| 4 anni |
| Alphonse H. L. Chan | M | - |
University of California, Irvine
University of California, Los Angeles
| 7 anni |
| Thomas P. Saint John | M | - | - | |
| Graham Walmsley | M | 37 |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | 3 anni |
| Andrei Iancu | M | - |
University of California, Los Angeles
| 5 anni |
| Glen Y. Sato | M | 65 |
University of California, Los Angeles
| 3 anni |
| Chi Hiu Robert Chow | M | - |
University of California, Los Angeles
| 6 anni |
| Ken Hertz | M | 66 |
University of California, Los Angeles
| 3 anni |
| Eric Chu | M | - |
University of California, Los Angeles
| 5 anni |
| Stephen M. Walbridge | M | - |
University of California, Los Angeles
| 4 anni |
| Chris Li | M | - |
University of California, Los Angeles
| 7 anni |
| David Stubbs | M | - |
University of California, Los Angeles
| 3 anni |
| Lee H. Hilborne | M | - |
University of California, Los Angeles
| 4 anni |
| Mollyann Brodie | M | - |
University of California, Los Angeles
| 4 anni |
| Ann I. Park | F | - |
University of California, Los Angeles
| 3 anni |
| Pamela Perry | F | - |
University of California, Los Angeles
| 4 anni |
| Geng Xiao | M | 61 |
University of California, Los Angeles
| 1 anni |
| De Yun Han | M | 61 |
University of California, Los Angeles
| 3 anni |
| Kutlug Ataman | M | 63 |
University of California, Los Angeles
| 2 anni |
| Margo Lee | F | - |
University of California, Los Angeles
| 5 anni |
| Berkeley Johnson | M | - |
University of California, Los Angeles
| 4 anni |
| Douglas E. Scott | M | 67 |
University of California, Los Angeles
| 3 anni |
| Chia Yue Chang | F | 63 |
University of California, Los Angeles
| 1 anni |
| Kurt S. Gunderson | M | - |
University of California, Los Angeles
| 5 anni |
| David Wang | M | 61 |
University of California, Los Angeles
| 4 anni |
| Alan Nathan Berro | M | - |
University of California, Los Angeles
| 4 anni |
| Jim S. Kang | M | - |
University of California, Los Angeles
| 4 anni |
| Stuart Peterson | M | - |
University of California, Los Angeles
| 4 anni |
| M. Edward Stearns | M | - |
University of California, Los Angeles
| 2 anni |
| Lynn Anderson Poole | F | - |
University of California, Los Angeles
| 5 anni |
| Ravi Rasendra Mazumdar | M | 69 |
University of California, Los Angeles
| 3 anni |
| Gary Ghazarian | M | - |
University of California, Los Angeles
| 4 anni |
| John Spottiswood | M | - |
University of California, Los Angeles
| 4 anni |
| Michael Leitner | M | 56 |
University of California, Los Angeles
| 4 anni |
| Robin Ann Gorelick | F | - |
University of California, Los Angeles
| 3 anni |
| Patrick Leahy | M | - |
University of California, Los Angeles
| 4 anni |
| Barry L. Goldner | M | - |
University of California, Los Angeles
| 3 anni |
| JP Leasure | M | - |
University of California, Los Angeles
| 4 anni |
| Randy R. Brugioni | M | 57 |
University of California, Los Angeles
| 4 anni |
| Karen A. Dempsey | F | - |
University of California, Los Angeles
| 4 anni |
| Bruce Lathrop | M | - |
University of California, Los Angeles
| 5 anni |
| Frank L. Buckley | M | - |
University of California, Los Angeles
| 5 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Paul Grayson
- Contatti personali
